NABCO Receives Support From Wal-Mart Foundation for In-Store Breast Health Program

Publication
Article
OncologyONCOLOGY Vol 11 No 9
Volume 11
Issue 9

The National Alliance of Breast Cancer Organizations (NABCO)-in a partnership with Oil of Olay-has received a $50,000 grant from the Wal-Mart Foundation in support of breast cancer awareness.

The National Alliance of Breast Cancer Organizations (NABCO)—in a partnershipwith Oil of Olay—has received a $50,000 grant from the Wal-Mart Foundationin support of breast cancer awareness.

Through free educational brochures made available in more than 3,000Oil of Olay product displays in Wal-Mart stores, NABCO is offering eachwoman help in establishing her own breast health program. Wal-Mart helpedto educate women by providing an opportunity to pick up a brochure or purchasean Oil of Olay skin care product labeled with NABCO's toll-free help line—1-800-719-9154.

"The Wal-Mart Foundation is proud to participate in supportingincreased awareness of an important health issue for women," saidEmerson Goodwin, Director of the Wal-Mart Foundation. "We hope torepeat this program in years to come."

NABCO's Executive Director Amy Langer, herself a breast cancer survivor,commented, "We are delighted by this new opportunity to reach women,and are grateful for the Wal-Mart Foundation's generous support of NABCO'soutreach programs. By bringing breast health information to women wherethey shop, we hope to make real progress in the fight against breast cancer."

In addition to supporting breast cancer education, in association withits vendors, stores, and customers, this year the Wal-Mart Foundation,based in Bentonville, Arkansas, will contribute nearly $81 million to localand national nonprofit organizations.

Recent Videos
Heather Zinkin, MD, states that reflexology improved pain from chemotherapy-induced neuropathy in patients undergoing radiotherapy for breast cancer.
Study findings reveal that patients with breast cancer reported overall improvement in their experience when receiving reflexology plus radiotherapy.
Patients undergoing radiotherapy for breast cancer were offered 15-minute nurse-led reflexology sessions to increase energy and reduce stress and pain.
Whole or accelerated partial breast ultra-hypofractionated radiation in older patients with early breast cancer may reduce recurrence with low toxicity.
Ultra-hypofractionated radiation in those 65 years or older with early breast cancer yielded no ipsilateral recurrence after a 10-month follow-up.
The unclear role of hypofractionated radiation in older patients with early breast cancer in prior trials incentivized research for this group.
Patients with HR-positive, HER2-positive breast cancer and high-risk features may derive benefit from ovarian function suppression plus endocrine therapy.
Paolo Tarantino, MD discusses updated breast cancer trial findings presented at ESMO 2024 supporting the use of agents such as T-DXd and ribociclib.
Paolo Tarantino, MD, discusses the potential utility of agents such as datopotamab deruxtecan and enfortumab vedotin in patients with breast cancer.
Paolo Tarantino, MD, highlights strategies related to screening and multidisciplinary collaboration for managing ILD in patients who receive T-DXd.